Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Demonstrating Systematic Endobronchial Ultrasound to New Endoscopists
Published on: August 11, 2023
Structure-activity insights and molecular modeling approaches of anti-TNBC agents: a comprehensive systematic review
Risqi Ayu Febriana1, Dhania Novitasari1,2, Nur Kusaira Khairul Ikram3
1Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
Aim:
Triple-negative breast cancer (TNBC) is a highly aggressive and treatment-resistant subtype of breast cancer, characterized by the lack of hormone receptor expression. This study aims to comprehensively evaluate the structure-activity relationship (SAR), structural modification, pharmacokinetic profiles, and molecular interaction of bioactive compounds developed for TNBC treatment from 2016 to February 2025.
Methods & Results:
Three identified publications were complemented by a selection of 19 articles, each adhering to predefined criteria. Modification of nitrogen heterocycles, phenolic compounds, β-lactams, and halogenated derivative compounds enhanced cytotoxic potency and selectivity against key targets, including CDK9, EGFR, FOXM1, PARP1, and tubulin.
Conclusion:
Strategic structural modifications significantly enhance the potency, selectivity, and pharmacokinetics of anti-TNBC agents. Future research should emphasize polypharmacology, advanced delivery strategies, and translational validation to address TNBC heterogeneity.
Insights
Structural modifications of bioactive compounds significantly improve treatment for triple-negative breast cancer (TNBC). This review details structure-activity relationships and pharmacokinetic profiles of novel anti-TNBC agents.
Area of Science:
- Medicinal Chemistry
- Oncology
- Pharmacology
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype lacking hormone receptors, presenting significant treatment challenges.
- Current therapeutic strategies for TNBC are limited due to its aggressive nature and resistance to standard treatments.
Purpose of the Study:
- To comprehensively evaluate the structure-activity relationship (SAR), structural modifications, pharmacokinetics, and molecular interactions of bioactive compounds for TNBC treatment.
- To review advancements in anti-TNBC agent development from 2016 to February 2025.
Main Methods:
- Systematic literature review of publications on TNBC therapeutics.
- Analysis of structural modifications in nitrogen heterocycles, phenolic compounds, beta-lactams, and halogenated derivatives.
- Evaluation of compound potency, selectivity, and pharmacokinetic profiles against key TNBC targets.
Main Results:
- Structural modifications of nitrogen heterocycles, phenolic compounds, beta-lactams, and halogenated derivatives enhanced cytotoxic potency and selectivity.
- Key molecular targets identified include CDK9, EGFR, FOXM1, PARP1, and tubulin.
- Strategic modifications improved pharmacokinetic profiles of anti-TNBC agents.
Conclusions:
- Structural modifications are crucial for enhancing the potency, selectivity, and pharmacokinetics of anti-TNBC agents.
- Future research should focus on polypharmacology and advanced delivery systems to combat TNBC heterogeneity.
- Translational validation of novel agents is essential for clinical application in TNBC treatment.
More Related Videos
Related Concept Videos
Molecular Models
Structure of Benzene: Molecular Orbital Model
Chemical Equilibria: Systematic Approach to Equilibrium Calculations
The first step is to identify all the chemical reactions involved, The...
Molecular Structure and Acidity
The size effect explains the change in atomic size on acidity. When comparing the acids formed from elements that belong to the same column in the periodic table, their atomic sizes...
Lewis Structures of Molecular Compounds and Polyatomic Ions
Acid Strength and Molecular Structure
In the absence of any leveling effect, the acid strength of binary compounds of hydrogen with nonmetals (A) increases as the H-A bond strength decreases down a group in the periodic table. For group 17, the order of increasing acidity is HF < HCl < HBr < HI. Likewise, for group 16, the order of increasing acid strength is H2O < H2S < H2Se < H2Te. Across a row in the periodic table, the acid strength of binary hydrogen compounds increases with increasing...

